Skip to main content

previous disabled Page of 4,654
and
  1. No Access

    Article

    Specific association between retinal neural layer thinning and neurological soft signs in schizophrenia

    There is growing evidence of disproportionate retinal thinning in schizophrenia, but doubts are still raised regarding its significance in the context of the neurobiology of the disease. Therefore, we examined...

    Paweł Krukow, Adam Domagała in European Archives of Psychiatry and Clinic… (2024)

  2. Article

    Cognitive horizons in chronic pain: unraveling neuroscientific insights and innovative interventions for fibromyalgia

    Jie Sun, **aoxing Liu, Lin Lu in European Archives of Psychiatry and Clinical Neuroscience (2024)

  3. No Access

    Article

    Negative symptoms and neurocognition in drug-naïve schizophrenia: moderating role of plasma neutrophil gelatinase-associated lipocalin (NGAL) and interferon-gamma (INF-γ)

    Previous studies reported that peripheral inflammation was associated with cognitive performance and brain structure in schizophrenia. However, the moderating effect of inflammation has not been extensively st...

    Meijuan Li, Guoshuai Luo, Yuying Qiu in European Archives of Psychiatry and Clinic… (2024)

  4. No Access

    Article

    GWAS of biological aging to find longevity genes in schizophrenia

    Schizophrenia (SCZ) is a severe psychotic disorder associated with premature mortality and aging. Moreover, the symptoms and progression of psychiatric disorders in general are associated with decreased lifesp...

    Jessica Qian, Corinne Fischer, Amer Burhan in European Archives of Psychiatry and Clinic… (2024)

  5. Article

    Open Access

    The association of SOD and HsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptoms

    Emerging evidence indicates a connection between oxidative stress, immune-inflammatory processes, and the negative symptoms of schizophrenia. In addition to possessing potent antioxidant and anti-inflammatory ...

    Jianfei Zeng, Weizhi Zhang, **aobing Lu in European Archives of Psychiatry and Clinic… (2024)

  6. No Access

    Article

    Genetic network structure of 13 psychiatric disorders in the general population

    Psychiatric disorders frequently co-occur and share common symptoms and genetic backgrounds. Previous research has used genome-wide association studies to identify the interrelationships among psychiatric diso...

    Hong Kyu Ihm, Hye** Kim, **ho Kim in European Archives of Psychiatry and Clinic… (2024)

  7. No Access

    Article

    Levels of brain-derived neurotrophic factor (BDNF) among patients with COVID-19: a systematic review and meta-analysis

    Many individuals have been suffering from consistent neurological and neuropsychiatric manifestations even after the remission of coronavirus disease (COVID-19). Brain-derived neurotrophic factor (BDNF) is a p...

    Arman Shafiee, Niloofar Seighali in European Archives of Psychiatry and Clinic… (2024)

  8. No Access

    Article

    Psychiatric features in NMDAR and LGI1 antibody–associated autoimmune encephalitis

    Patients with autoimmune encephalitis (AE) often developed psychiatric features during the disease course. Many studies focused on the psychiatric characteristic in anti-NMDAR encephalitis (NMDAR-E), but anti-...

    Yu Jia, Mingyu Li, Shimin Hu, Haixia Leng in European Archives of Psychiatry and Clinic… (2024)

  9. Article

    Open Access

    The myth of brain damage: no change of neurofilament light chain during transient cognitive side-effects of ECT

    Electroconvulsive therapy (ECT) is an effective, safe, and mostly well-tolerated treatment for patients with severe or difficult to treat depression or psychotic disorders. However, a relevant number of patien...

    Matthias Besse, Michael Belz in European Archives of Psychiatry and Clinic… (2024)

  10. Article

    Open Access

    Soluble terminal complement complex blood levels are elevated in schizophrenia

    The role of the complement system in schizophrenia (Sz) is inconclusive due to heterogeneity of the disease and study designs. Here, we assessed the levels of complement activation products and functionality o...

    Susa Savukoski, Marco Mannes in European Archives of Psychiatry and Clinic… (2024)

  11. No Access

    Article

    Role of HOMA-IR and IL-6 as screening markers for the metabolic syndrome in patients with chronic schizophrenia: a psychiatric hospital-based cross-sectional study

    This study starts from the metabolic related indexes and cellular inflammatory factors in patients with chronic schizophrenia to find out that it can be used as an effective screening index of metabolic syndro...

    ** Yuan, Qiongyao Yang, Yitan Yao in European Archives of Psychiatry and Clinic… (2024)

  12. Article

    Open Access

    Gender differences in clinical and biochemical parameters among patients hospitalized for schizophrenia: towards precision medicine

    The scientific literature shows some gender differences in the clinical course of schizophrenia. The aim of this study is to identify gender differences in clinical and biochemical parameters in subjects affec...

    Cecilia Maria Esposito, Francesca De Cagna in European Archives of Psychiatry and Clinic… (2024)

  13. No Access

    Article

    Retinal layers and symptoms and inflammation in schizophrenia

    Schizophrenia is a neurodevelopmental disorder that affects brain structure and function. The retina, as well as the brain, consists of neuronal and glial cells packed in layers. Cortical volume and brain thic...

    Marcelo Alves Carriello in European Archives of Psychiatry and Clinic… (2024)

  14. No Access

    Article

    Effects of antipsychotic drugs on energy metabolism

    Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly...

    Bruna Panizzutti, Chiara C. Bortolasci in European Archives of Psychiatry and Clinic… (2024)

  15. Article

    Open Access

    Microbiome composition and central serotonergic activity in patients with depression and type 1 diabetes

    The role of gut–brain axis functioning gains growing attention in research on the pathophysiology of major depressive disorders. Here, especially consequences of altered microbiota composition on tryptophan me...

    Vera Flasbeck, Julia Hirsch, Frank Petrak in European Archives of Psychiatry and Clinic… (2024)

  16. No Access

    Article

    Positive association between increased homocysteine and deficit syndrome in Chinese patients with chronic schizophrenia: a large-scale cross-sectional study

    Emerging studies indicate that oxidative stress may contribute to deficit syndrome (DS) in patients with schizophrenia. Homocysteine (Hcy) is a well-known marker and mediator of oxidative stress that exhibits ...

    Pu Peng, Dongmei Wang, Qian** Wang in European Archives of Psychiatry and Clinic… (2024)

  17. No Access

    Article

    Plasma Apo-E mediated corticospinal tract abnormalities and suicidality in patients with major depressive disorder

    This study aims to explore the link between Apo-E, brain white matter, and suicide in patients with major depressive disorder (MDD) to investigate the potential neuroimmune mechanisms of Apo-E that may lead to...

    **aoxia Lei, **nyu Fang, Juanjuan Ren in European Archives of Psychiatry and Clinic… (2024)

  18. No Access

    Article

    Neural mechanisms underlying attentional bias modification in fibromyalgia patients: a double-blind ERP study

    There is a growing interest in the potential benefits of attentional bias modification (ABM) training in chronic pain patients. However, studies examining the effectiveness of ABM programs in fibromyalgia pati...

    Roberto Fernandes-Magalhaes, Alberto Carpio in European Archives of Psychiatry and Clinic… (2024)

  19. Article

    Open Access

    Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers

    Individuals with schizophrenia and bipolar disorder are at an increased risk of cardiovascular disease (CVD), and a range of biomarkers related to CVD risk have been found to be abnormal in these patients. Com...

    Elina J. Reponen, Thor Ueland in European Archives of Psychiatry and Clinic… (2024)

  20. Article

    Open Access

    Deconstructing depression by machine learning: the POKAL-PSY study

    Unipolar depression is a prevalent and disabling condition, often left untreated. In the outpatient setting, general practitioners fail to recognize depression in about 50% of cases mainly due to somatic comor...

    Julia Eder, Lisa Pfeiffer, Sven P. Wichert in European Archives of Psychiatry and Clinic… (2024)

previous disabled Page of 4,654